PharmaBoardroom & Focus Reports Sponsor ETIF 2014
“We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines…
Bioceres is an Argentina-based firm that manages investments in agricultural biotechnology and related sciences. It was founded in December 2001 by 23 farmers and is now owned by more than 270 shareholders, most of them innovative farmers but also coops and different actors from the agro-industrial sector. Every year, Bioceres shareholders plant about 2.5 million hectares in different regions of Latin America.
Since its beginnings, Bioceres has been a bridge between the scientific community and the agricultural production sector, fostering public-private associations and the development of collaborative networks.
Bioceres is a firm open to new shareholders with a shared dream-developing new technologies that help us use natural resources in a more efficient way while increasing and stabilizing the productivity of ecosystems.
Bioceres goes from genes to seeds, linking the laboratory to the field, adding value in every stage, and building and strengthening public-private partnerships.
CONTACT DETAILS
Ocampo 210 bis, predio CCT Rosario, (2000) Rosario, Santa Fe, Argentina
Phone: (54) 341 486 1100 Fax:(54) 341 486 1100
“We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines…
President of the company, Alberto Alvarez-Saavedra, discusses the company’s transformation into a professional organization, and the strategy which has driven remarkable growth in recent years, and will continue to do so…
On behalf of the chamber of industry that represents research-based pharma and biopharma companies in Argentina, Ernesto Felicio discusses the current challenges facing the industry, and the chambers current agenda…
Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how that strategy is implemented in Argentina and…
Gabriela Pittis discusses the Argentinian healthcare system’s ability to diagnose, treat, and regulate rare diseases, and the country’s progress in further developing what is already the region’s most comprehensive system…
The director general of the Argentina, Uruguay and Paraguay region for Sanofi discusses the strength of the Argentinian healthcare system and the key, but subdued, role that multinational pharmaceutical companies…
The general manager of Argentia weighs up the factors that have led to his company consolidating its different business lines and becoming one of the fastest growing companies in Argentina.…
Hugo Sigman explains how understanding problems in the same way as opportunities helped his company to become what is today, a successful Argentinian conglomerate where life and science is the…
The National Scientific and Technical Research Council (CONICET) is the main organization in charge of the promotion of science and technology in Argentina. Santiago Villa and Marian Berenstein, general manager and…
The National Scientific and Technical Research Council (CONICET) is the main organization in charge of the promotion of science and technology in Argentina. Santiago Villa and Marian Berenstein, general manager and…
The National Scientific and Technical Research Council (CONICET) is the main organization in charge of the promotion of science and technology in Argentina. Santiago Villa and Marian Berenstein, general manager and…
Bioceres manages investments in agricultural biotechnology and related sciences. The company’s CEO, Federico Trucco, discusses the potential of Argentina’s biotech scene to become a world-class drug developer in biopharma as…
See our Cookie Privacy Policy Here
